Chemoinformaics analysis of METHYL 2-[(1R,2S)-3-OXO-2-[(Z)-PENT-2-ENYL]CYCLOPENTYL]ACETATE
Molecular Weight | 224.3 | nRot | 5 |
Heavy Atom Molecular Weight | 204.14 | nRig | 7 |
Exact Molecular Weight | 224.141 | nRing | 1 |
Solubility: LogS | -2.936 | nHRing | 0 |
Solubility: LogP | 3.664 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 36 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 1 |
No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 13 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
nHA | 3 | APOL | 37.4519 |
nHD | 0 | BPOL | 23.5361 |
QED | 0.138 |
Synth | 4.277 |
Natural Product Likeliness | 1.502 |
NR-PPAR-gamma | 0.006 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.021 |
Pgp-sub | 0.042 |
HIA | 0.944 |
CACO-2 | -5.153 |
MDCK | 0.0000322 |
BBB | 0.16 |
PPB | 0.810745 |
VDSS | 0.543 |
FU | 0.142209 |
CYP1A2-inh | 0.012 |
CYP1A2-sub | 0.118 |
CYP2c19-inh | 0.015 |
CYP2c19-sub | 0.847 |
CYP2c9-inh | 0.003 |
CYP2c9-sub | 0.905 |
CYP2d6-inh | 0.042 |
CYP2d6-sub | 0.643 |
CYP3a4-inh | 0.025 |
CYP3a4-sub | 0.07 |
CL | 1.977 |
T12 | 0.118 |
hERG | 0.135 |
Ames | 0.355 |
ROA | 0.271 |
SkinSen | 0.193 |
Carcinogencity | 0.035 |
EI | 0.008 |
Respiratory | 0.812 |
NR-Aromatase | 0.255 |
Antiviral | Yes |
Prediction | 0.704607 |